Theratechnologies Inc. Common
THTX Real Time Price USDRecent trades of THTX by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by THTX's directors and management
Government lobbying spending instances
Estimated quarterly lobbying spending
THTX Revenue by Segment or Geography
No Revenue by Segment data for this ticker
No Revenue by Geography data for this ticker
New patents grants
-
Patent Title: Peptide compounds derived from melanotransferrin and uses thereof May. 10, 2016
-
Patent Title: Formulations of growth hormone releasing factor (grf) molecules with improved stability Oct. 28, 2014
-
Patent Title: Bifunctional hormone having alpha-msh activity and natriuretic peptide activity and uses thereof Sep. 02, 2014
-
Patent Title: Gh secretagogues and uses thereof Jul. 09, 2013
-
Patent Title: Gh secretagogues and uses thereof May. 07, 2013
-
Patent Title: Growth hormone releasing factor (grf) analogs and uses thereof Jan. 29, 2013
-
Patent Title: Gh secretagogues and uses thereof Nov. 20, 2012
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Recent insights relating to THTX
Number of mentions of THTX in WallStreetBets Daily Discussion
Recent picks made for THTX stock on CNBC
ETFs with the largest estimated holdings in THTX
|
Shareholder
|
Shares Held
|
|---|
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view THTX Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.